Canadian HIV Vaccine Initiative program areas
Program areas under the Renewed Canadian HIV Vaccine Initiative are:
- Advancing Basic Science - activities will be supported to strengthen the capacity of and promote greater involvement and collaboration amongst researchers in Canada and in low-and-middle-income countries who are working in HIV vaccine discovery and social research.
- Translating Basic Science into Clinical Trials - activities will be supported to assist researchers, in the public and private sectors, in moving promising HIV vaccine candidates from preclinical research into clinical trials in humans.
- Addressing Enabling Conditions - activities will be supported that involve domestic and international stakeholders in addressing HIV vaccines policy issues, building capacity and promoting global harmonization of regulatory pathways, and improving preparedness.
- Preventing Mother-to-Child Transmission of HIV - activities will be supported that will improve the efficacy and effectiveness of PMTCT in low-and-middle-income countries, by enhancing the availability, quality and uptake of PMTCT services.
- Supporting a Coordinated Approach (GoC and Alliance) - activities will provide coordination support and infrastructure to ensure a strong network of HIV vaccine researchers and other vaccine researchers both in Canada and internationally; and ensure effective communications, strategic planning, coordination, reporting and evaluation within the Government of Canada.
|Key Areas of Focus||GoC||BMGF||Total|
|HIV Vaccines||Advancing Basic Science||$27M||$7M||$34M|
|Translating Research into Clinical Trials||$34M||$14M||$48M|
|Addressing Enabling Conditions||$13M||$7M||$20M|
|Prevention of Mother-to-Child Transmission of HIV||$30M||$0||$30M|
|Supporting a Coordinated Approach
(GoC and Alliance)
Report a problem or mistake on this page
- Date modified: